Christopher E. Touloukian

Tumor-specific Th17-polarized cells eradicate large established melanoma

Pawel Muranski, Andrea Boni, Paul A. Antony et al. · Blood · 2008 · 830 citations · Full text

Medicine, Immunology, Oncology +12

Vaccination with a recombinant vaccinia virus encoding a “self” antigen induces autoimmune vitiligo and tumor cell destruction in mice: Requirement for CD4 ⁺ T lymphocytes

Willem W. Overwijk, David Lee, Deborah R. Surman et al. · Proceedings of the National Academy of Sciences · 1999 · 382 citations

Life Sciences, Immunology, Oncology +17

Identification of CD4+ T Cell Epitopes from NY-ESO-1 Presented by HLA-DR Molecules

Gang Zeng, Christopher E. Touloukian, Xiang Wang et al. · The Journal of Immunology · 2000 · 146 citations · Full text

Life Sciences, Immunology, Oncology +17

Identification of a MHC Class II-Restricted Human gp100 Epitope Using DR4-IE Transgenic Mice

Christopher E. Touloukian, Wolfgang W. Leitner, Suzanne L. Topalian et al. · The Journal of Immunology · 2000 · 125 citations · Full text

Life Sciences, Biotechnology, Immunology +17

Immunization of Patients with Metastatic Melanoma Using Both Class I- and Class II-Restricted Peptides from Melanoma-Associated Antigens

Giao Q. Phan, Christopher E. Touloukian, James C. Yang et al. · Journal of Immunotherapy · 2003 · 112 citations

Life Sciences, Immunology, Oncology +17